Header Logo

Beth Holly Resman-Targoff

TitleProf,Clin
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPharmacy Clinical & Admin Sci
AddressCPB 205
1110 N Stonewall Ave
Oklahoma City OK 73117
Phone405/271-6878 ext 47261
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Epperson TM, Bennett KK, Kupiec KK, Speigel K, Neely SB, Resman-Targoff BH, Kinney KK, White BP. Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center - ADDENDUM. Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e240. PMID: 38156214; PMCID: PMC10753504.
      Citations:    
    2. Epperson TM, Bennett KK, Kupiec KK, Speigel K, Neely SB, Resman-Targoff BH, Kinney KK, White BP. Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center. Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e15. PMID: 36714295; PMCID: PMC9879875.
      Citations: 1     
    3. Fox AN, Smith WJ, Kupiec KE, Harding SJ, Resman-Targoff BH, Neely SB, White BP, Owens RE. Daptomycin dosing in obese patients: analysis of the use of adjusted body weight versus actual body weight. Ther Adv Infect Dis. 2019 Jan-Dec; 6:2049936118820230. PMID: 30728962.
      Citations: 4     
    4. Gleason BL, Peeters MJ, Resman-Targoff BH, Karr S, McBane S, Kelley K, Thomas T, Denetclaw TH. An active-learning strategies primer for achieving ability-based educational outcomes. Am J Pharm Educ. 2011 Nov 10; 75(9):186. PMID: 22171114.
      Citations: 74     Fields:    Translation:Humans
    5. Resman-Targoff BH, Cicero MP. Aggressive treatment of early rheumatoid arthritis: recognizing the window of opportunity and treating to target goals. Am J Manag Care. 2010 11; 16(9 Suppl):S249-58. PMID: 21517638.
      Citations: 10     Fields:    Translation:Humans
    6. Haase KK, Smythe MA, Orlando PL, Resman-Targoff BH, Smith LS, Herner SJ, Dee Melnyk S, Paolini NM, Porter KB, Rodgers PT, Spunt AL. Quality experiential education. Pharmacotherapy. 2008 Dec; 28(12):1547. PMID: 19025437.
      Citations: 11     Fields:    Translation:Humans
    7. Haase KK, Smythe MA, Orlando PL, Resman-Targoff BH, Smith LS. Ensuring quality experiential education. Pharmacotherapy. 2008 Dec; 28(12):1548-51. PMID: 19025438.
      Citations: 18     Fields:    Translation:Humans
    8. Rowley AK, Resman-Targoff BH, Marra CA, Pucino F. Evolution of clinical pharmacy in the practice of rheumatology. Ann Pharmacother. 2007 Oct; 41(10):1705-7. PMID: 17848418.
      Citations: 1     Fields:    Translation:Humans
    9. Resman-Targoff BH. Medical therapy: where are we now? Am J Health Syst Pharm. 2006 Sep 15; 63(18 Suppl 4):S11-8. PMID: 16960243.
      Citations: 1     Fields:    Translation:Humans
    10. Brown JR, Marra C, Pucino F, Resman-Targoff BH. Improving rheumatoid arthritis outcomes: how do we get there? Am J Health Syst Pharm. 2006 Sep 15; 63(18 Suppl 4):S42-4. PMID: 16960247.
      Citations:    Fields:    Translation:Humans
    11. Chen JT, Pucino F, Resman-Targoff BH. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?. J Pain Palliat Care Pharmacother. 2006; 20(4):11-32. PMID: 17182503.
      Citations: 2     Fields:    Translation:Humans
    12. Mihm LB, Rathbun RC, Resman-Targoff BH. Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome. Pharmacotherapy. 1995 Nov-Dec; 15(6):793-7. PMID: 8602391.
      Citations: 2     Fields:    Translation:Humans
    13. Delafuente JC, Resman-Targoff BH. Monoclonal antibodies in the treatment of rheumatoid arthritis. Ann Pharmacother. 1994 May; 28(5):650-4. PMID: 8069005.
      Citations:    Fields:    Translation:HumansAnimals
    14. Horton S, Resman-Targoff BH, Thompson DF. Use of cyclosporine in rheumatoid arthritis. Ann Pharmacother. 1993 Jan; 27(1):44-6. PMID: 8431620.
      Citations: 1     Fields:    Translation:Humans
    15. Resman-Targoff BH. Ketorolac: a parenteral nonsteroidal antiinflammatory drug. DICP. 1990 Nov; 24(11):1098-104. PMID: 2275236.
      Citations: 6     Fields:    Translation:Humans
    Resman-Targoff's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (77)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _